• Mashup Score: 1

    ESMO is Europe’s leading medical oncology society, providing a professional network for its members and working with national societies across Europe.

    Tweet Tweets with this article
    • Just out 📢 The ESMO #GastricCancer Living Guideline. Updates in 1st-, 2nd- & further lines of tx of advanced/metastatic unresectable #OesophagealCancer, #OesophagogastricJunctionCancer & #GastricAdenocarcinoma; & supportive care & nutrition. 🔗 https://t.co/XxmGo356Pq #esocsm https://t.co/7LYaeqBrmC

  • Mashup Score: 0

    First-line treatment with zolbetuximab added to chemotherapy significantly extended OS and PFS among adults with certain forms of claudin-18.2-positive/HER2-negative gastric adenocarcinoma, results of the phase 3 SPOTLIGHT trial showed.Study participants, who had locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma, demonstrated a 25% reduction in risk

    Tweet Tweets with this article
    • Zolbetuximab benefits subset of patients with gastric, gastroesophageal junction cancer. https://t.co/f6oZybULVQ #GastroesophagealJunctionCancer #zolbetuximab #GastricAdenocarcinoma @AstellasUS